KDM6B histone demethylase is an epigenetic regulator of estrogen receptor β expression in human pleural mesothelioma.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To assess the correlation between KDM6B and estrogen receptor β (ERβ) expression in malignant pleural mesothelioma (MPM).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Epigenomics

Title: Epigenomics

Publisher: Future Medicine Ltd

ISSN (Electronic): 1750-192X

ISSN (Print): 1750-192X

Publication date (Electronic): Sep 2016

Volume: 8

Issue: 9

Affiliations

[1 ] Department of Pharmaceutical Sciences, University of Piemonte Orientale, Lgo Donegani 2, 28100 Novara, Italy.

[2 ] Laboratory of Cellular Biochemistry & Molecular Biology, CRIBENS, Catholic University of the Sacred Heart, 20145 Milan, Italy.

[3 ] Sidra Medical & Research Center, P.O. Box 26999 Doha, Qatar.

[4 ] University of Leicester & Leicester University Hospitals, LE1 9HN, Leicester, UK.

[5 ] Department of Biosciences & Nutrition, Karolinska Institutet, S-141 57 Huddinge, Sweden.

Article

DOI: 10.2217/epi-2016-0025

PubMed ID: 27529370

SO-VID: 0f302bcf-5993-4ea9-ab5d-e4e21d126b68

History

Keywords: KDM6B,H3K27me3,epigenetic,human malignant pleural mesothelioma,ERβ

Data availability:

Keywords: KDM6B, H3K27me3, epigenetic, human malignant pleural mesothelioma, ERβ

KDM6B histone demethylase is an epigenetic regulator of estrogen receptor β expression in human pleural mesothelioma.

Read this article at

Abstract

Related collections

Measurement of Glucocorticoid Receptor Signaling in Major Depression

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 9